BRPI0519064A2 - uso de derivados de Ácido ciclo propano substituÍdos para produÇço de fÁrmacos para uso no tratamento de sÍndrome metabàlica - Google Patents
uso de derivados de Ácido ciclo propano substituÍdos para produÇço de fÁrmacos para uso no tratamento de sÍndrome metabàlicaInfo
- Publication number
- BRPI0519064A2 BRPI0519064A2 BRPI0519064-9A BRPI0519064A BRPI0519064A2 BR PI0519064 A2 BRPI0519064 A2 BR PI0519064A2 BR PI0519064 A BRPI0519064 A BR PI0519064A BR PI0519064 A2 BRPI0519064 A2 BR PI0519064A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- metabolic syndrome
- acid derivatives
- drug production
- substituted cyclopropane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
USO DE DERIVADOS DE ÁCIDO CICLO PROPANO SUBSTITUIDOS PARA PRODUÇçO DE FÁRMACOS PARA USO NO TRATAMENTO DE SÍNDROME METABàLICA. A presente invenção refere-se ao uso de derivados de ciclo propano substituidos e seus sais fisiologicamente aceitáveis para produção de fármaco para uso no tratamento de síndrome metabólica. De acordo com a invenção, os compostos de fórmula (I), em que os substituintes são definidos como indicado, e seus sais fisiologicamente aceitáveis são usados para produção de um fármaco para tratamento de síndrome metabólica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004060041A DE102004060041A1 (de) | 2004-12-14 | 2004-12-14 | Verwendung von substituierten Cyclopropansäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
DE102005039245 | 2005-08-19 | ||
PCT/EP2005/012763 WO2006063681A1 (de) | 2004-12-14 | 2005-11-30 | Verwendung von substituierten cyclopropansäurederivaten zur herstellung von medikamenten zur behandlung des metabolischen syndroms |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519064A2 true BRPI0519064A2 (pt) | 2008-12-23 |
Family
ID=35945136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519064-9A BRPI0519064A2 (pt) | 2004-12-14 | 2005-11-30 | uso de derivados de Ácido ciclo propano substituÍdos para produÇço de fÁrmacos para uso no tratamento de sÍndrome metabàlica |
Country Status (20)
Country | Link |
---|---|
US (2) | US20080045590A1 (pt) |
EP (1) | EP1827415B1 (pt) |
JP (1) | JP2008523122A (pt) |
KR (1) | KR20070086194A (pt) |
AR (1) | AR052265A1 (pt) |
AT (1) | ATE455543T1 (pt) |
AU (1) | AU2005315975A1 (pt) |
BR (1) | BRPI0519064A2 (pt) |
CA (1) | CA2590024A1 (pt) |
DE (1) | DE502005008929D1 (pt) |
IL (1) | IL183464A0 (pt) |
MA (1) | MA29131B1 (pt) |
MX (1) | MX2007006798A (pt) |
MY (1) | MY138165A (pt) |
NO (1) | NO20073031L (pt) |
NZ (1) | NZ555155A (pt) |
RU (1) | RU2007126842A (pt) |
TW (1) | TW200635575A (pt) |
UY (1) | UY29256A1 (pt) |
WO (1) | WO2006063681A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8053867B2 (en) * | 2008-08-20 | 2011-11-08 | Honeywell International Inc. | Phosphorous-comprising dopants and methods for forming phosphorous-doped regions in semiconductor substrates using phosphorous-comprising dopants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4497815B2 (ja) * | 2001-02-16 | 2010-07-07 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 新規な複素環式アミド誘導体およびドーパミンd3受容体リガンドとしてのその使用 |
EP1458694A4 (en) * | 2001-12-20 | 2005-12-14 | Merck & Co Inc | THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEAMIC CONDITIONS |
PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
-
2005
- 2005-11-30 BR BRPI0519064-9A patent/BRPI0519064A2/pt not_active IP Right Cessation
- 2005-11-30 CA CA002590024A patent/CA2590024A1/en not_active Abandoned
- 2005-11-30 RU RU2007126842/15A patent/RU2007126842A/ru not_active Application Discontinuation
- 2005-11-30 DE DE502005008929T patent/DE502005008929D1/de active Active
- 2005-11-30 AT AT05814551T patent/ATE455543T1/de not_active IP Right Cessation
- 2005-11-30 MX MX2007006798A patent/MX2007006798A/es not_active Application Discontinuation
- 2005-11-30 KR KR1020077013437A patent/KR20070086194A/ko not_active Application Discontinuation
- 2005-11-30 AU AU2005315975A patent/AU2005315975A1/en not_active Abandoned
- 2005-11-30 NZ NZ555155A patent/NZ555155A/en not_active IP Right Cessation
- 2005-11-30 JP JP2007545874A patent/JP2008523122A/ja not_active Abandoned
- 2005-11-30 EP EP05814551A patent/EP1827415B1/de active Active
- 2005-11-30 WO PCT/EP2005/012763 patent/WO2006063681A1/de active Application Filing
- 2005-12-12 AR ARP050105191A patent/AR052265A1/es not_active Application Discontinuation
- 2005-12-12 TW TW094143771A patent/TW200635575A/zh unknown
- 2005-12-13 MY MYPI20055838A patent/MY138165A/en unknown
- 2005-12-20 UY UY29256A patent/UY29256A1/es unknown
-
2007
- 2007-05-28 IL IL183464A patent/IL183464A0/en unknown
- 2007-06-07 US US11/759,510 patent/US20080045590A1/en not_active Abandoned
- 2007-06-12 MA MA29989A patent/MA29131B1/fr unknown
- 2007-06-14 NO NO20073031A patent/NO20073031L/no not_active Application Discontinuation
-
2008
- 2008-12-04 US US12/328,052 patent/US8222240B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
UY29256A1 (es) | 2006-07-31 |
WO2006063681A1 (de) | 2006-06-22 |
EP1827415A1 (de) | 2007-09-05 |
MY138165A (en) | 2009-04-30 |
EP1827415B1 (de) | 2010-01-20 |
IL183464A0 (en) | 2007-10-31 |
NO20073031L (no) | 2007-08-03 |
MX2007006798A (es) | 2007-08-07 |
US20080045590A1 (en) | 2008-02-21 |
TW200635575A (en) | 2006-10-16 |
JP2008523122A (ja) | 2008-07-03 |
US8222240B2 (en) | 2012-07-17 |
KR20070086194A (ko) | 2007-08-27 |
DE502005008929D1 (de) | 2010-03-11 |
AR052265A1 (es) | 2007-03-07 |
NZ555155A (en) | 2009-09-25 |
ATE455543T1 (de) | 2010-02-15 |
CA2590024A1 (en) | 2006-06-22 |
AU2005315975A1 (en) | 2006-06-22 |
US20090088474A1 (en) | 2009-04-02 |
RU2007126842A (ru) | 2009-01-27 |
MA29131B1 (fr) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0410760A (pt) | compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos | |
BR112013000248A2 (pt) | derivados de dióxido de 1,3-propano espirociclicamente substituído, método para a produção dos mesmos e uso dos mesmos como medicamento | |
BR112014008686A2 (pt) | derivados de oxazina e uso dos mesmos no tratamento de doença | |
BRPI0613570A8 (pt) | composto ou um sal do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar doenças mediadas por glk, e, processo para a preparação de um composto. | |
PE20210667A1 (es) | Derivados de benzamida para la inhibicion de la actividad abl1, abl2 y bcr-abl1 | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
BR112012013322A2 (pt) | derivados de amino oxazina | |
BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
BRPI0817060A2 (pt) | composto, processo para a preparação destes compostos, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são modulados por agonistas receptores de hormônio da tireóide e usos destes compostos | |
BRPI0915592A2 (pt) | composto agonista do receptor de gpr119, processo para a preparação do composto, composição farmacêutica que o compreende, uso do mesmo e método para o tratamento ou profilaxia de diabetes mellitus do tipo ii | |
BR112014013974A8 (pt) | derivados de sulfonamida benzílicos como moduladores de rorc | |
BR112014007193A2 (pt) | derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos | |
BRPI0519674A2 (pt) | sulfonil pirrolidinas, mÉtodo para produzir as mesmas e seu uso como drogas | |
BRPI0518898A2 (pt) | composto, processo para sua preparaÇço, composiÇço farmacÊutica, mÉtodo para tratamento e uso do composto | |
BR112013000282A2 (pt) | derivados do ácido (2-arilóxi-acetilamino)-fenil-propiônico, método para produzir o mesmo e a utilização dos mesmos como produtos farmacêuticos | |
BRPI0519329A2 (pt) | Ácidos hidroxibifenil carboxÍlicos e derivados, mÉtodos para produÇço dos mesmos e uso dos mesmos | |
UY30472A1 (es) | Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones. | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
BR112014011850A8 (pt) | Derivados de aminopirimidina, seus usos, e composição farmacêutica | |
BRPI0513086A (pt) | 8-pirrolidinoxantinas bicìclicas substituìdas, processo para a produção das mesmas e seu uso como medicamentos | |
BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
BRPI0512237A (pt) | cis-imidazolinas | |
UY31069A1 (es) | Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones | |
PE20120648A1 (es) | Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1 | |
BR112015006436A2 (pt) | novas piridinonas bicíclicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |